Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul D Kassner

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Combinatorial Chemistry & High Throughput Screening|March 14, 2008
Discovery of novel targets with high throughput RNA interference screeningPaul D Kassner
Expert Opinion on Therapeutic Targets|August 5, 2009
RNA interference screening for the discovery of oncology targetsKim Quon, Paul D Kassner
Biotechniques|July 7, 2007
Multiple displacement amplification products are compatible with recombination-based cloningMikhal Ben Jakov, Paul D Kassner
Neuron|April 10, 2015
Cell-based screening: extracting meaning from complex dataSteven Finkbeiner, Michael Frumkin, Paul D Kassner
Genome Research|November 9, 2007
Significant gene content variation characterizes the genomes of inbred mouse strainsGene Cutler, Lisa A Marshall, Ni Chin, et al.
Journal of Biomolecular Screening|April 8, 2010
Use of cryopreserved cell aliquots in the high-throughput screening of small interfering RNA librariesElissa A Swearingen, Flordeliza Fajardo, Xiangyun Wang, et al.
Plos One|July 11, 2013
Measurement of Cancer Cell Growth Heterogeneity through Lentiviral Barcoding Identifies Clonal Dominance as a Characteristic of In Vivo Tumor EngraftmentOlivier Nolan-Stevaux, Donato Tedesco, Seamus Ragan, et al.
Autophagy|April 7, 2016
Identification of modulators of autophagic flux in an image-based high content siRNA screenChristopher M Hale, Qingwen Cheng, Danny Ortuno, et al.
Plos Pathogens|January 13, 2022
EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22Aparna Jorapur, Lisa A Marshall, Scott Jacobson, et al.
Allergy|November 20, 2023
Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 studyRobert Bissonnette, Janet DuBois, Paola Facheris, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Combinatorial Chemistry & High Throughput Screening|March 14, 2008
Discovery of novel targets with high throughput RNA interference screeningPaul D Kassner
Expert Opinion on Therapeutic Targets|August 5, 2009
RNA interference screening for the discovery of oncology targetsKim Quon, Paul D Kassner
Biotechniques|July 7, 2007
Multiple displacement amplification products are compatible with recombination-based cloningMikhal Ben Jakov, Paul D Kassner
Neuron|April 10, 2015
Cell-based screening: extracting meaning from complex dataSteven Finkbeiner, Michael Frumkin, Paul D Kassner
Genome Research|November 9, 2007
Significant gene content variation characterizes the genomes of inbred mouse strainsGene Cutler, Lisa A Marshall, Ni Chin, et al.
Journal of Biomolecular Screening|April 8, 2010
Use of cryopreserved cell aliquots in the high-throughput screening of small interfering RNA librariesElissa A Swearingen, Flordeliza Fajardo, Xiangyun Wang, et al.
Plos One|July 11, 2013
Measurement of Cancer Cell Growth Heterogeneity through Lentiviral Barcoding Identifies Clonal Dominance as a Characteristic of In Vivo Tumor EngraftmentOlivier Nolan-Stevaux, Donato Tedesco, Seamus Ragan, et al.
Autophagy|April 7, 2016
Identification of modulators of autophagic flux in an image-based high content siRNA screenChristopher M Hale, Qingwen Cheng, Danny Ortuno, et al.
Plos Pathogens|January 13, 2022
EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22Aparna Jorapur, Lisa A Marshall, Scott Jacobson, et al.
Allergy|November 20, 2023
Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 studyRobert Bissonnette, Janet DuBois, Paola Facheris, et al.
Pageof 2